Loading…
Reduction of malaria case incidence following the introduction of clothianidin-based indoor residual spraying in previously unsprayed districts: an observational analysis using health facility register data from Côte d’Ivoire, 2018–2022
BackgroundIndoor residual spraying (IRS) using neonicotinoid-based insecticides (clothianidin and combined clothianidin with deltamethrin) was deployed in two previously unsprayed districts of Côte d’Ivoire in 2020 and 2021 to complement standard pyrethroid insecticide-treated nets. This retrospecti...
Saved in:
Published in: | BMJ global health 2024-03, Vol.9 (3), p.e013324 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-b484t-e95d09bdafe21f35e6b75710d75ef54f5997b2eb216906a81a9448a4efcb16903 |
container_end_page | |
container_issue | 3 |
container_start_page | e013324 |
container_title | BMJ global health |
container_volume | 9 |
creator | Hilton, Emily R Gning-Cisse, Ndombour Assi, Auguste Eyakou, Mathieu Koffi, John Gnakou, Barthelemy Kouassi, Bernard Flatley, Cecilia Chabi, Joseph Gbalegba, Constant Alex Aimain, Serge Yah Kokrasset, Colette Antoine Tanoh, Mea N'Gotta, Sylvain Yao, Octavie Egou Assi, Hughes Konan, Philomène Davis, Kelly Constant, Edi Belemvire, Allison Yepassis-Zembrou, Patricia Zinzindohoue, Pascal Kouadio, Blaise Burnett, Sarah |
description | BackgroundIndoor residual spraying (IRS) using neonicotinoid-based insecticides (clothianidin and combined clothianidin with deltamethrin) was deployed in two previously unsprayed districts of Côte d’Ivoire in 2020 and 2021 to complement standard pyrethroid insecticide-treated nets. This retrospective observational study uses health facility register data to assess the impact of IRS on clinically reported malaria case incidence.MethodsHealth facility data were abstracted from consultation registers for the period September 2018 to April 2022 in two IRS districts and two control districts that did not receive IRS. Malaria cases reported by community health workers (CHWs) were obtained from district reports and District Health Information Systems 2. Facilities missing complete data were excluded. Controlled interrupted time series models were used to estimate the effect of IRS on monthly all-ages population-adjusted confirmed malaria cases and cases averted by IRS. Models controlled for transmission season, precipitation, vegetation, temperature, proportion of cases reported by CHWs, proportion of tested out of suspected cases and non-malaria outpatient visits.ResultsAn estimated 10 988 (95% CI 5694 to 18 188) malaria cases were averted in IRS districts the year following the 2020 IRS campaign, representing a 15.9% reduction compared with if IRS had not been deployed. Case incidence in IRS districts dropped by 27.7% (incidence rate ratio (IRR) 0.723, 95% CI 0.592 to 0.885) the month after the campaign. In the 8 months after the 2021 campaign, 14 170 (95% CI 13 133 to 15 025) estimated cases were averted, a 24.7% reduction, and incidence in IRS districts dropped by 37.9% (IRR 0.621, 95% CI 0.462 to 0.835) immediately after IRS. Case incidence in control districts did not change following IRS either year (p>0.05) and the difference in incidence level change between IRS and control districts was significant both years (p |
doi_str_mv | 10.1136/bmjgh-2023-013324 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4f8d1636fc954d7c9809ff0ebbbad9ed</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4f8d1636fc954d7c9809ff0ebbbad9ed</doaj_id><sourcerecordid>3030816367</sourcerecordid><originalsourceid>FETCH-LOGICAL-b484t-e95d09bdafe21f35e6b75710d75ef54f5997b2eb216906a81a9448a4efcb16903</originalsourceid><addsrcrecordid>eNp1kk1uFDEQhVsIRKKQA7BBltiwoMHuf7NBUcRPpEhICNZW2S7PeORpD7Z70OxyB1bcgxtwk9yAG-DOhJAgsXFb5fe9crteUTxm9AVjdfdSrleLZVnRqi4pq-uquVccVrTlZc_pcP_W_qA4jnFFKWV9Xmj3sDioh5ZxyrvD4tdH1JNK1o_EG7IGB8ECURCR2FFZjaNCYrxz_qsdFyQt53oK_haknE9LC6PVdixlJnWWaO8DCRitnsCRuAmwm3k7kk3ArfVTdDsyjVcHGdA2pmBViq8IZFMZMWxhbpBhyMsu2kimOFssEVxaEgPKOpt2uckiwxiIhgTEBL8mpz9_JCT68uL72dbbgM9JRdlwefEtv1b1qHhgwEU8vv4eFZ_fvvl0-r48__Du7PTkvJTN0KQSeasplxoMVszULXayb3tGdd-iaRvTct7LCmXFOk47GBjwphmgQaPkXKqPirO9r_awEptg1xB2woMVVwUfFgJCssqhaMygWVd3RvG20b3iA-XGUJRSguaos9frvddmkmvUCvMIwN0xvXsy2qVY-K1gecispX12eHbtEPyXCWMSaxsVOgcj5mGIivcNpXVXz9Kn_0hXfgp5CFHUtKbDfNNZxfYqFXyMAc3NbRgVc0DFVUDFHFCxD2hmntz-jRviTxyzoNwLMvu36_8NfwN74PnV</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3030816367</pqid></control><display><type>article</type><title>Reduction of malaria case incidence following the introduction of clothianidin-based indoor residual spraying in previously unsprayed districts: an observational analysis using health facility register data from Côte d’Ivoire, 2018–2022</title><source>BMJ Open Access Journals</source><source>PubMed Central Free</source><creator>Hilton, Emily R ; Gning-Cisse, Ndombour ; Assi, Auguste ; Eyakou, Mathieu ; Koffi, John ; Gnakou, Barthelemy ; Kouassi, Bernard ; Flatley, Cecilia ; Chabi, Joseph ; Gbalegba, Constant ; Alex Aimain, Serge ; Yah Kokrasset, Colette ; Antoine Tanoh, Mea ; N'Gotta, Sylvain ; Yao, Octavie ; Egou Assi, Hughes ; Konan, Philomène ; Davis, Kelly ; Constant, Edi ; Belemvire, Allison ; Yepassis-Zembrou, Patricia ; Zinzindohoue, Pascal ; Kouadio, Blaise ; Burnett, Sarah</creator><creatorcontrib>Hilton, Emily R ; Gning-Cisse, Ndombour ; Assi, Auguste ; Eyakou, Mathieu ; Koffi, John ; Gnakou, Barthelemy ; Kouassi, Bernard ; Flatley, Cecilia ; Chabi, Joseph ; Gbalegba, Constant ; Alex Aimain, Serge ; Yah Kokrasset, Colette ; Antoine Tanoh, Mea ; N'Gotta, Sylvain ; Yao, Octavie ; Egou Assi, Hughes ; Konan, Philomène ; Davis, Kelly ; Constant, Edi ; Belemvire, Allison ; Yepassis-Zembrou, Patricia ; Zinzindohoue, Pascal ; Kouadio, Blaise ; Burnett, Sarah</creatorcontrib><description>BackgroundIndoor residual spraying (IRS) using neonicotinoid-based insecticides (clothianidin and combined clothianidin with deltamethrin) was deployed in two previously unsprayed districts of Côte d’Ivoire in 2020 and 2021 to complement standard pyrethroid insecticide-treated nets. This retrospective observational study uses health facility register data to assess the impact of IRS on clinically reported malaria case incidence.MethodsHealth facility data were abstracted from consultation registers for the period September 2018 to April 2022 in two IRS districts and two control districts that did not receive IRS. Malaria cases reported by community health workers (CHWs) were obtained from district reports and District Health Information Systems 2. Facilities missing complete data were excluded. Controlled interrupted time series models were used to estimate the effect of IRS on monthly all-ages population-adjusted confirmed malaria cases and cases averted by IRS. Models controlled for transmission season, precipitation, vegetation, temperature, proportion of cases reported by CHWs, proportion of tested out of suspected cases and non-malaria outpatient visits.ResultsAn estimated 10 988 (95% CI 5694 to 18 188) malaria cases were averted in IRS districts the year following the 2020 IRS campaign, representing a 15.9% reduction compared with if IRS had not been deployed. Case incidence in IRS districts dropped by 27.7% (incidence rate ratio (IRR) 0.723, 95% CI 0.592 to 0.885) the month after the campaign. In the 8 months after the 2021 campaign, 14 170 (95% CI 13 133 to 15 025) estimated cases were averted, a 24.7% reduction, and incidence in IRS districts dropped by 37.9% (IRR 0.621, 95% CI 0.462 to 0.835) immediately after IRS. Case incidence in control districts did not change following IRS either year (p>0.05) and the difference in incidence level change between IRS and control districts was significant both years (p<0.05).ConclusionDeployment of clothianidin-based IRS was associated with a reduction in malaria case rates in two districts of Côte d’Ivoire following IRS deployment in 2020 and 2021.</description><identifier>ISSN: 2059-7908</identifier><identifier>EISSN: 2059-7908</identifier><identifier>DOI: 10.1136/bmjgh-2023-013324</identifier><identifier>PMID: 38519096</identifier><language>eng</language><publisher>England: BMJ Publishing Group Ltd</publisher><subject>Censuses ; Cote d'Ivoire - epidemiology ; Data collection ; Deltamethrin ; epidemiology ; Guanidines ; Health Facilities ; Households ; Humans ; Incidence ; Insecticides ; Intervention ; Malaria ; Malaria - epidemiology ; Malaria - prevention & control ; Mortality ; Mosquito Control ; Neonicotinoids ; Observational studies ; Original Research ; Pesticides ; Population ; public health ; Pyrethroids ; Spraying ; Thiazoles ; Vector-borne diseases</subject><ispartof>BMJ global health, 2024-03, Vol.9 (3), p.e013324</ispartof><rights>Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-b484t-e95d09bdafe21f35e6b75710d75ef54f5997b2eb216906a81a9448a4efcb16903</cites><orcidid>0000-0001-9319-5203 ; 0000-0003-3217-3398</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://gh.bmj.com/content/9/3/e013324.full.pdf$$EPDF$$P50$$Gbmj$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://gh.bmj.com/content/9/3/e013324.full$$EHTML$$P50$$Gbmj$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793,55350,77660,77686</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38519096$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hilton, Emily R</creatorcontrib><creatorcontrib>Gning-Cisse, Ndombour</creatorcontrib><creatorcontrib>Assi, Auguste</creatorcontrib><creatorcontrib>Eyakou, Mathieu</creatorcontrib><creatorcontrib>Koffi, John</creatorcontrib><creatorcontrib>Gnakou, Barthelemy</creatorcontrib><creatorcontrib>Kouassi, Bernard</creatorcontrib><creatorcontrib>Flatley, Cecilia</creatorcontrib><creatorcontrib>Chabi, Joseph</creatorcontrib><creatorcontrib>Gbalegba, Constant</creatorcontrib><creatorcontrib>Alex Aimain, Serge</creatorcontrib><creatorcontrib>Yah Kokrasset, Colette</creatorcontrib><creatorcontrib>Antoine Tanoh, Mea</creatorcontrib><creatorcontrib>N'Gotta, Sylvain</creatorcontrib><creatorcontrib>Yao, Octavie</creatorcontrib><creatorcontrib>Egou Assi, Hughes</creatorcontrib><creatorcontrib>Konan, Philomène</creatorcontrib><creatorcontrib>Davis, Kelly</creatorcontrib><creatorcontrib>Constant, Edi</creatorcontrib><creatorcontrib>Belemvire, Allison</creatorcontrib><creatorcontrib>Yepassis-Zembrou, Patricia</creatorcontrib><creatorcontrib>Zinzindohoue, Pascal</creatorcontrib><creatorcontrib>Kouadio, Blaise</creatorcontrib><creatorcontrib>Burnett, Sarah</creatorcontrib><title>Reduction of malaria case incidence following the introduction of clothianidin-based indoor residual spraying in previously unsprayed districts: an observational analysis using health facility register data from Côte d’Ivoire, 2018–2022</title><title>BMJ global health</title><addtitle>BMJ Glob Health</addtitle><addtitle>BMJ Glob Health</addtitle><description>BackgroundIndoor residual spraying (IRS) using neonicotinoid-based insecticides (clothianidin and combined clothianidin with deltamethrin) was deployed in two previously unsprayed districts of Côte d’Ivoire in 2020 and 2021 to complement standard pyrethroid insecticide-treated nets. This retrospective observational study uses health facility register data to assess the impact of IRS on clinically reported malaria case incidence.MethodsHealth facility data were abstracted from consultation registers for the period September 2018 to April 2022 in two IRS districts and two control districts that did not receive IRS. Malaria cases reported by community health workers (CHWs) were obtained from district reports and District Health Information Systems 2. Facilities missing complete data were excluded. Controlled interrupted time series models were used to estimate the effect of IRS on monthly all-ages population-adjusted confirmed malaria cases and cases averted by IRS. Models controlled for transmission season, precipitation, vegetation, temperature, proportion of cases reported by CHWs, proportion of tested out of suspected cases and non-malaria outpatient visits.ResultsAn estimated 10 988 (95% CI 5694 to 18 188) malaria cases were averted in IRS districts the year following the 2020 IRS campaign, representing a 15.9% reduction compared with if IRS had not been deployed. Case incidence in IRS districts dropped by 27.7% (incidence rate ratio (IRR) 0.723, 95% CI 0.592 to 0.885) the month after the campaign. In the 8 months after the 2021 campaign, 14 170 (95% CI 13 133 to 15 025) estimated cases were averted, a 24.7% reduction, and incidence in IRS districts dropped by 37.9% (IRR 0.621, 95% CI 0.462 to 0.835) immediately after IRS. Case incidence in control districts did not change following IRS either year (p>0.05) and the difference in incidence level change between IRS and control districts was significant both years (p<0.05).ConclusionDeployment of clothianidin-based IRS was associated with a reduction in malaria case rates in two districts of Côte d’Ivoire following IRS deployment in 2020 and 2021.</description><subject>Censuses</subject><subject>Cote d'Ivoire - epidemiology</subject><subject>Data collection</subject><subject>Deltamethrin</subject><subject>epidemiology</subject><subject>Guanidines</subject><subject>Health Facilities</subject><subject>Households</subject><subject>Humans</subject><subject>Incidence</subject><subject>Insecticides</subject><subject>Intervention</subject><subject>Malaria</subject><subject>Malaria - epidemiology</subject><subject>Malaria - prevention & control</subject><subject>Mortality</subject><subject>Mosquito Control</subject><subject>Neonicotinoids</subject><subject>Observational studies</subject><subject>Original Research</subject><subject>Pesticides</subject><subject>Population</subject><subject>public health</subject><subject>Pyrethroids</subject><subject>Spraying</subject><subject>Thiazoles</subject><subject>Vector-borne diseases</subject><issn>2059-7908</issn><issn>2059-7908</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>9YT</sourceid><sourceid>DOA</sourceid><recordid>eNp1kk1uFDEQhVsIRKKQA7BBltiwoMHuf7NBUcRPpEhICNZW2S7PeORpD7Z70OxyB1bcgxtwk9yAG-DOhJAgsXFb5fe9crteUTxm9AVjdfdSrleLZVnRqi4pq-uquVccVrTlZc_pcP_W_qA4jnFFKWV9Xmj3sDioh5ZxyrvD4tdH1JNK1o_EG7IGB8ECURCR2FFZjaNCYrxz_qsdFyQt53oK_haknE9LC6PVdixlJnWWaO8DCRitnsCRuAmwm3k7kk3ArfVTdDsyjVcHGdA2pmBViq8IZFMZMWxhbpBhyMsu2kimOFssEVxaEgPKOpt2uckiwxiIhgTEBL8mpz9_JCT68uL72dbbgM9JRdlwefEtv1b1qHhgwEU8vv4eFZ_fvvl0-r48__Du7PTkvJTN0KQSeasplxoMVszULXayb3tGdd-iaRvTct7LCmXFOk47GBjwphmgQaPkXKqPirO9r_awEptg1xB2woMVVwUfFgJCssqhaMygWVd3RvG20b3iA-XGUJRSguaos9frvddmkmvUCvMIwN0xvXsy2qVY-K1gecispX12eHbtEPyXCWMSaxsVOgcj5mGIivcNpXVXz9Kn_0hXfgp5CFHUtKbDfNNZxfYqFXyMAc3NbRgVc0DFVUDFHFCxD2hmntz-jRviTxyzoNwLMvu36_8NfwN74PnV</recordid><startdate>20240322</startdate><enddate>20240322</enddate><creator>Hilton, Emily R</creator><creator>Gning-Cisse, Ndombour</creator><creator>Assi, Auguste</creator><creator>Eyakou, Mathieu</creator><creator>Koffi, John</creator><creator>Gnakou, Barthelemy</creator><creator>Kouassi, Bernard</creator><creator>Flatley, Cecilia</creator><creator>Chabi, Joseph</creator><creator>Gbalegba, Constant</creator><creator>Alex Aimain, Serge</creator><creator>Yah Kokrasset, Colette</creator><creator>Antoine Tanoh, Mea</creator><creator>N'Gotta, Sylvain</creator><creator>Yao, Octavie</creator><creator>Egou Assi, Hughes</creator><creator>Konan, Philomène</creator><creator>Davis, Kelly</creator><creator>Constant, Edi</creator><creator>Belemvire, Allison</creator><creator>Yepassis-Zembrou, Patricia</creator><creator>Zinzindohoue, Pascal</creator><creator>Kouadio, Blaise</creator><creator>Burnett, Sarah</creator><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>9YT</scope><scope>ACMMV</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9319-5203</orcidid><orcidid>https://orcid.org/0000-0003-3217-3398</orcidid></search><sort><creationdate>20240322</creationdate><title>Reduction of malaria case incidence following the introduction of clothianidin-based indoor residual spraying in previously unsprayed districts: an observational analysis using health facility register data from Côte d’Ivoire, 2018–2022</title><author>Hilton, Emily R ; Gning-Cisse, Ndombour ; Assi, Auguste ; Eyakou, Mathieu ; Koffi, John ; Gnakou, Barthelemy ; Kouassi, Bernard ; Flatley, Cecilia ; Chabi, Joseph ; Gbalegba, Constant ; Alex Aimain, Serge ; Yah Kokrasset, Colette ; Antoine Tanoh, Mea ; N'Gotta, Sylvain ; Yao, Octavie ; Egou Assi, Hughes ; Konan, Philomène ; Davis, Kelly ; Constant, Edi ; Belemvire, Allison ; Yepassis-Zembrou, Patricia ; Zinzindohoue, Pascal ; Kouadio, Blaise ; Burnett, Sarah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b484t-e95d09bdafe21f35e6b75710d75ef54f5997b2eb216906a81a9448a4efcb16903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Censuses</topic><topic>Cote d'Ivoire - epidemiology</topic><topic>Data collection</topic><topic>Deltamethrin</topic><topic>epidemiology</topic><topic>Guanidines</topic><topic>Health Facilities</topic><topic>Households</topic><topic>Humans</topic><topic>Incidence</topic><topic>Insecticides</topic><topic>Intervention</topic><topic>Malaria</topic><topic>Malaria - epidemiology</topic><topic>Malaria - prevention & control</topic><topic>Mortality</topic><topic>Mosquito Control</topic><topic>Neonicotinoids</topic><topic>Observational studies</topic><topic>Original Research</topic><topic>Pesticides</topic><topic>Population</topic><topic>public health</topic><topic>Pyrethroids</topic><topic>Spraying</topic><topic>Thiazoles</topic><topic>Vector-borne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hilton, Emily R</creatorcontrib><creatorcontrib>Gning-Cisse, Ndombour</creatorcontrib><creatorcontrib>Assi, Auguste</creatorcontrib><creatorcontrib>Eyakou, Mathieu</creatorcontrib><creatorcontrib>Koffi, John</creatorcontrib><creatorcontrib>Gnakou, Barthelemy</creatorcontrib><creatorcontrib>Kouassi, Bernard</creatorcontrib><creatorcontrib>Flatley, Cecilia</creatorcontrib><creatorcontrib>Chabi, Joseph</creatorcontrib><creatorcontrib>Gbalegba, Constant</creatorcontrib><creatorcontrib>Alex Aimain, Serge</creatorcontrib><creatorcontrib>Yah Kokrasset, Colette</creatorcontrib><creatorcontrib>Antoine Tanoh, Mea</creatorcontrib><creatorcontrib>N'Gotta, Sylvain</creatorcontrib><creatorcontrib>Yao, Octavie</creatorcontrib><creatorcontrib>Egou Assi, Hughes</creatorcontrib><creatorcontrib>Konan, Philomène</creatorcontrib><creatorcontrib>Davis, Kelly</creatorcontrib><creatorcontrib>Constant, Edi</creatorcontrib><creatorcontrib>Belemvire, Allison</creatorcontrib><creatorcontrib>Yepassis-Zembrou, Patricia</creatorcontrib><creatorcontrib>Zinzindohoue, Pascal</creatorcontrib><creatorcontrib>Kouadio, Blaise</creatorcontrib><creatorcontrib>Burnett, Sarah</creatorcontrib><collection>BMJ Open Access Journals</collection><collection>BMJ Journals:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMJ global health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hilton, Emily R</au><au>Gning-Cisse, Ndombour</au><au>Assi, Auguste</au><au>Eyakou, Mathieu</au><au>Koffi, John</au><au>Gnakou, Barthelemy</au><au>Kouassi, Bernard</au><au>Flatley, Cecilia</au><au>Chabi, Joseph</au><au>Gbalegba, Constant</au><au>Alex Aimain, Serge</au><au>Yah Kokrasset, Colette</au><au>Antoine Tanoh, Mea</au><au>N'Gotta, Sylvain</au><au>Yao, Octavie</au><au>Egou Assi, Hughes</au><au>Konan, Philomène</au><au>Davis, Kelly</au><au>Constant, Edi</au><au>Belemvire, Allison</au><au>Yepassis-Zembrou, Patricia</au><au>Zinzindohoue, Pascal</au><au>Kouadio, Blaise</au><au>Burnett, Sarah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduction of malaria case incidence following the introduction of clothianidin-based indoor residual spraying in previously unsprayed districts: an observational analysis using health facility register data from Côte d’Ivoire, 2018–2022</atitle><jtitle>BMJ global health</jtitle><stitle>BMJ Glob Health</stitle><addtitle>BMJ Glob Health</addtitle><date>2024-03-22</date><risdate>2024</risdate><volume>9</volume><issue>3</issue><spage>e013324</spage><pages>e013324-</pages><issn>2059-7908</issn><eissn>2059-7908</eissn><abstract>BackgroundIndoor residual spraying (IRS) using neonicotinoid-based insecticides (clothianidin and combined clothianidin with deltamethrin) was deployed in two previously unsprayed districts of Côte d’Ivoire in 2020 and 2021 to complement standard pyrethroid insecticide-treated nets. This retrospective observational study uses health facility register data to assess the impact of IRS on clinically reported malaria case incidence.MethodsHealth facility data were abstracted from consultation registers for the period September 2018 to April 2022 in two IRS districts and two control districts that did not receive IRS. Malaria cases reported by community health workers (CHWs) were obtained from district reports and District Health Information Systems 2. Facilities missing complete data were excluded. Controlled interrupted time series models were used to estimate the effect of IRS on monthly all-ages population-adjusted confirmed malaria cases and cases averted by IRS. Models controlled for transmission season, precipitation, vegetation, temperature, proportion of cases reported by CHWs, proportion of tested out of suspected cases and non-malaria outpatient visits.ResultsAn estimated 10 988 (95% CI 5694 to 18 188) malaria cases were averted in IRS districts the year following the 2020 IRS campaign, representing a 15.9% reduction compared with if IRS had not been deployed. Case incidence in IRS districts dropped by 27.7% (incidence rate ratio (IRR) 0.723, 95% CI 0.592 to 0.885) the month after the campaign. In the 8 months after the 2021 campaign, 14 170 (95% CI 13 133 to 15 025) estimated cases were averted, a 24.7% reduction, and incidence in IRS districts dropped by 37.9% (IRR 0.621, 95% CI 0.462 to 0.835) immediately after IRS. Case incidence in control districts did not change following IRS either year (p>0.05) and the difference in incidence level change between IRS and control districts was significant both years (p<0.05).ConclusionDeployment of clothianidin-based IRS was associated with a reduction in malaria case rates in two districts of Côte d’Ivoire following IRS deployment in 2020 and 2021.</abstract><cop>England</cop><pub>BMJ Publishing Group Ltd</pub><pmid>38519096</pmid><doi>10.1136/bmjgh-2023-013324</doi><orcidid>https://orcid.org/0000-0001-9319-5203</orcidid><orcidid>https://orcid.org/0000-0003-3217-3398</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2059-7908 |
ispartof | BMJ global health, 2024-03, Vol.9 (3), p.e013324 |
issn | 2059-7908 2059-7908 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_4f8d1636fc954d7c9809ff0ebbbad9ed |
source | BMJ Open Access Journals; PubMed Central Free |
subjects | Censuses Cote d'Ivoire - epidemiology Data collection Deltamethrin epidemiology Guanidines Health Facilities Households Humans Incidence Insecticides Intervention Malaria Malaria - epidemiology Malaria - prevention & control Mortality Mosquito Control Neonicotinoids Observational studies Original Research Pesticides Population public health Pyrethroids Spraying Thiazoles Vector-borne diseases |
title | Reduction of malaria case incidence following the introduction of clothianidin-based indoor residual spraying in previously unsprayed districts: an observational analysis using health facility register data from Côte d’Ivoire, 2018–2022 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T05%3A14%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduction%20of%20malaria%20case%20incidence%20following%20the%20introduction%20of%20clothianidin-based%20indoor%20residual%20spraying%20in%20previously%20unsprayed%20districts:%20an%20observational%20analysis%20using%20health%20facility%20register%20data%20from%20C%C3%B4te%20d%E2%80%99Ivoire,%202018%E2%80%932022&rft.jtitle=BMJ%20global%20health&rft.au=Hilton,%20Emily%20R&rft.date=2024-03-22&rft.volume=9&rft.issue=3&rft.spage=e013324&rft.pages=e013324-&rft.issn=2059-7908&rft.eissn=2059-7908&rft_id=info:doi/10.1136/bmjgh-2023-013324&rft_dat=%3Cproquest_doaj_%3E3030816367%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b484t-e95d09bdafe21f35e6b75710d75ef54f5997b2eb216906a81a9448a4efcb16903%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3030816367&rft_id=info:pmid/38519096&rfr_iscdi=true |